Aditxt Stock Down 58.5 %
Aditxt stock opened at $4.31 on Friday. The business has a 50 day moving average of $19.66 and a 200-day moving average of $17.09. Aditxt has a 1 year low of $4.30 and a 1 year high of $136.00.
Aditxt (NASDAQ:ADTX – Get Rating) last released its quarterly earnings data on Monday, August 15th. The company reported ($6.50) earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($12.00). The firm had revenue of $0.22 million during the quarter, compared to the consensus estimate of $10.44 million. On average, sell-side analysts anticipate that Aditxt will post -12 EPS for the current year.
Institutional Trading of Aditxt
Aditxt Company Profile
Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.
- Get a free copy of the StockNews.com research report on Aditxt (ADTX)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.